Consensus statements on adherence issues in schizophrenia for Hong Kong

Abstract Aim In view of the clinical importance of the adherence issues in schizophrenia management, a consensus group of experienced local psychiatrists and nurse specialists gathered to outline a number of consensus statements for clinicians to consider enhancing adherence in their patients. Proce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Asian journal of psychiatry 2014-12, Vol.12, p.163-169
Hauptverfasser: Mak, K.Y, Lo, W.T.L, Yeung, W.S, Wong, Michael, Chung, W.S.D, Chui, E, Tam, Ka-Lok, Hui, L.K, Mui, Jolene, Chan, O.W, Wong, K.L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 169
container_issue
container_start_page 163
container_title Asian journal of psychiatry
container_volume 12
creator Mak, K.Y
Lo, W.T.L
Yeung, W.S
Wong, Michael
Chung, W.S.D
Chui, E
Tam, Ka-Lok
Hui, L.K
Mui, Jolene
Chan, O.W
Wong, K.L
description Abstract Aim In view of the clinical importance of the adherence issues in schizophrenia management, a consensus group of experienced local psychiatrists and nurse specialists gathered to outline a number of consensus statements for clinicians to consider enhancing adherence in their patients. Process Prior to the consensus group meeting, three core members drafted eight statements on the issue of adherence in schizophrenia. Using a modified Delphi method, published literature and published guidelines regarding the management of schizophrenia were reviewed by the full panel during the group meeting. After discussion and reflection from each individual member of the consensus group, the eight statements were reworded and electronically voted on anonymously in two steps: acceptance on quality of evidence and practicability in implementation. Results After modifications of the original statements, there was very high overall level of agreement and acceptance (reaching international standard) on all the five areas of adherence within the eight statements of the finalised statement. Conclusions The present consensus statements are the first in Hong Kong to address systematically adherence issues in schizophrenia management. They include areas on adherence assessment and definition, treatment strategies in enhancing adherence, and treatment considerations at specific phases of schizophrenia. They are tailored to be of practical utility in the local Hong Kong setting.
doi_str_mv 10.1016/j.ajp.2014.06.018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1629959214</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1876201814001750</els_id><sourcerecordid>1629959214</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-5b3ba91d43585e6d1f94f1944970eac860921f07b6f3f6141bf056c035bc2fa53</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhSMEoqXwA7igHLlsOpPYTiIkJLSCtqISB-BsOc6Yddi1F09Sqfx6HG3pgQMX27Lee5r5XlG8RqgQUF1OlZmOVQ0oKlAVYPekOMeuVZsaavX08Y3dWfGCeQJQXSPa58VZLYUA2cJ5cbWNgSnwwiXPZqYDhZnLGEoz7ihRsFR65oW49KFku_O_43GX_70pXUzldQw_ys_5eFk8c2bP9Orhvii-f_r4bXu9uf1ydbP9cLuxQuK8kUMzmB5H0chOkhrR9cJhL0TfAhnbKehrdNAOyjVOocDBgVQWGjnY2hnZXBRvT7nHFH_lsWZ98GxpvzeB4sIaVd33MoeILMWT1KbInMjpY_IHk-41gl756Ulnfnrlp0HpzCl73jzEL8OBxkfHX2BZ8O4koLzknaek2foV0-gT2VmP0f83_v0_brv3wVuz_0n3xFNcUsj0NGquNeiva4FrfygAsJXQ_AHDkJSZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1629959214</pqid></control><display><type>article</type><title>Consensus statements on adherence issues in schizophrenia for Hong Kong</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Mak, K.Y ; Lo, W.T.L ; Yeung, W.S ; Wong, Michael ; Chung, W.S.D ; Chui, E ; Tam, Ka-Lok ; Hui, L.K ; Mui, Jolene ; Chan, O.W ; Wong, K.L</creator><creatorcontrib>Mak, K.Y ; Lo, W.T.L ; Yeung, W.S ; Wong, Michael ; Chung, W.S.D ; Chui, E ; Tam, Ka-Lok ; Hui, L.K ; Mui, Jolene ; Chan, O.W ; Wong, K.L</creatorcontrib><description>Abstract Aim In view of the clinical importance of the adherence issues in schizophrenia management, a consensus group of experienced local psychiatrists and nurse specialists gathered to outline a number of consensus statements for clinicians to consider enhancing adherence in their patients. Process Prior to the consensus group meeting, three core members drafted eight statements on the issue of adherence in schizophrenia. Using a modified Delphi method, published literature and published guidelines regarding the management of schizophrenia were reviewed by the full panel during the group meeting. After discussion and reflection from each individual member of the consensus group, the eight statements were reworded and electronically voted on anonymously in two steps: acceptance on quality of evidence and practicability in implementation. Results After modifications of the original statements, there was very high overall level of agreement and acceptance (reaching international standard) on all the five areas of adherence within the eight statements of the finalised statement. Conclusions The present consensus statements are the first in Hong Kong to address systematically adherence issues in schizophrenia management. They include areas on adherence assessment and definition, treatment strategies in enhancing adherence, and treatment considerations at specific phases of schizophrenia. They are tailored to be of practical utility in the local Hong Kong setting.</description><identifier>ISSN: 1876-2018</identifier><identifier>EISSN: 1876-2026</identifier><identifier>DOI: 10.1016/j.ajp.2014.06.018</identifier><identifier>PMID: 25440570</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adherence ; Antipsychotic Agents - therapeutic use ; Consensus ; Consensus statements ; Delphi Technique ; Hong Kong ; Humans ; Internal Medicine ; Medication Adherence ; Psychiatry ; Schizophrenia ; Schizophrenia - drug therapy</subject><ispartof>Asian journal of psychiatry, 2014-12, Vol.12, p.163-169</ispartof><rights>The Authors</rights><rights>2014 The Authors</rights><rights>Copyright © 2014 The Authors. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-5b3ba91d43585e6d1f94f1944970eac860921f07b6f3f6141bf056c035bc2fa53</citedby><cites>FETCH-LOGICAL-c451t-5b3ba91d43585e6d1f94f1944970eac860921f07b6f3f6141bf056c035bc2fa53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ajp.2014.06.018$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25440570$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mak, K.Y</creatorcontrib><creatorcontrib>Lo, W.T.L</creatorcontrib><creatorcontrib>Yeung, W.S</creatorcontrib><creatorcontrib>Wong, Michael</creatorcontrib><creatorcontrib>Chung, W.S.D</creatorcontrib><creatorcontrib>Chui, E</creatorcontrib><creatorcontrib>Tam, Ka-Lok</creatorcontrib><creatorcontrib>Hui, L.K</creatorcontrib><creatorcontrib>Mui, Jolene</creatorcontrib><creatorcontrib>Chan, O.W</creatorcontrib><creatorcontrib>Wong, K.L</creatorcontrib><title>Consensus statements on adherence issues in schizophrenia for Hong Kong</title><title>Asian journal of psychiatry</title><addtitle>Asian J Psychiatr</addtitle><description>Abstract Aim In view of the clinical importance of the adherence issues in schizophrenia management, a consensus group of experienced local psychiatrists and nurse specialists gathered to outline a number of consensus statements for clinicians to consider enhancing adherence in their patients. Process Prior to the consensus group meeting, three core members drafted eight statements on the issue of adherence in schizophrenia. Using a modified Delphi method, published literature and published guidelines regarding the management of schizophrenia were reviewed by the full panel during the group meeting. After discussion and reflection from each individual member of the consensus group, the eight statements were reworded and electronically voted on anonymously in two steps: acceptance on quality of evidence and practicability in implementation. Results After modifications of the original statements, there was very high overall level of agreement and acceptance (reaching international standard) on all the five areas of adherence within the eight statements of the finalised statement. Conclusions The present consensus statements are the first in Hong Kong to address systematically adherence issues in schizophrenia management. They include areas on adherence assessment and definition, treatment strategies in enhancing adherence, and treatment considerations at specific phases of schizophrenia. They are tailored to be of practical utility in the local Hong Kong setting.</description><subject>Adherence</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Consensus</subject><subject>Consensus statements</subject><subject>Delphi Technique</subject><subject>Hong Kong</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medication Adherence</subject><subject>Psychiatry</subject><subject>Schizophrenia</subject><subject>Schizophrenia - drug therapy</subject><issn>1876-2018</issn><issn>1876-2026</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFv1DAQhSMEoqXwA7igHLlsOpPYTiIkJLSCtqISB-BsOc6Yddi1F09Sqfx6HG3pgQMX27Lee5r5XlG8RqgQUF1OlZmOVQ0oKlAVYPekOMeuVZsaavX08Y3dWfGCeQJQXSPa58VZLYUA2cJ5cbWNgSnwwiXPZqYDhZnLGEoz7ihRsFR65oW49KFku_O_43GX_70pXUzldQw_ys_5eFk8c2bP9Orhvii-f_r4bXu9uf1ydbP9cLuxQuK8kUMzmB5H0chOkhrR9cJhL0TfAhnbKehrdNAOyjVOocDBgVQWGjnY2hnZXBRvT7nHFH_lsWZ98GxpvzeB4sIaVd33MoeILMWT1KbInMjpY_IHk-41gl756Ulnfnrlp0HpzCl73jzEL8OBxkfHX2BZ8O4koLzknaek2foV0-gT2VmP0f83_v0_brv3wVuz_0n3xFNcUsj0NGquNeiva4FrfygAsJXQ_AHDkJSZ</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Mak, K.Y</creator><creator>Lo, W.T.L</creator><creator>Yeung, W.S</creator><creator>Wong, Michael</creator><creator>Chung, W.S.D</creator><creator>Chui, E</creator><creator>Tam, Ka-Lok</creator><creator>Hui, L.K</creator><creator>Mui, Jolene</creator><creator>Chan, O.W</creator><creator>Wong, K.L</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141201</creationdate><title>Consensus statements on adherence issues in schizophrenia for Hong Kong</title><author>Mak, K.Y ; Lo, W.T.L ; Yeung, W.S ; Wong, Michael ; Chung, W.S.D ; Chui, E ; Tam, Ka-Lok ; Hui, L.K ; Mui, Jolene ; Chan, O.W ; Wong, K.L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-5b3ba91d43585e6d1f94f1944970eac860921f07b6f3f6141bf056c035bc2fa53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adherence</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Consensus</topic><topic>Consensus statements</topic><topic>Delphi Technique</topic><topic>Hong Kong</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medication Adherence</topic><topic>Psychiatry</topic><topic>Schizophrenia</topic><topic>Schizophrenia - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mak, K.Y</creatorcontrib><creatorcontrib>Lo, W.T.L</creatorcontrib><creatorcontrib>Yeung, W.S</creatorcontrib><creatorcontrib>Wong, Michael</creatorcontrib><creatorcontrib>Chung, W.S.D</creatorcontrib><creatorcontrib>Chui, E</creatorcontrib><creatorcontrib>Tam, Ka-Lok</creatorcontrib><creatorcontrib>Hui, L.K</creatorcontrib><creatorcontrib>Mui, Jolene</creatorcontrib><creatorcontrib>Chan, O.W</creatorcontrib><creatorcontrib>Wong, K.L</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Asian journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mak, K.Y</au><au>Lo, W.T.L</au><au>Yeung, W.S</au><au>Wong, Michael</au><au>Chung, W.S.D</au><au>Chui, E</au><au>Tam, Ka-Lok</au><au>Hui, L.K</au><au>Mui, Jolene</au><au>Chan, O.W</au><au>Wong, K.L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Consensus statements on adherence issues in schizophrenia for Hong Kong</atitle><jtitle>Asian journal of psychiatry</jtitle><addtitle>Asian J Psychiatr</addtitle><date>2014-12-01</date><risdate>2014</risdate><volume>12</volume><spage>163</spage><epage>169</epage><pages>163-169</pages><issn>1876-2018</issn><eissn>1876-2026</eissn><abstract>Abstract Aim In view of the clinical importance of the adherence issues in schizophrenia management, a consensus group of experienced local psychiatrists and nurse specialists gathered to outline a number of consensus statements for clinicians to consider enhancing adherence in their patients. Process Prior to the consensus group meeting, three core members drafted eight statements on the issue of adherence in schizophrenia. Using a modified Delphi method, published literature and published guidelines regarding the management of schizophrenia were reviewed by the full panel during the group meeting. After discussion and reflection from each individual member of the consensus group, the eight statements were reworded and electronically voted on anonymously in two steps: acceptance on quality of evidence and practicability in implementation. Results After modifications of the original statements, there was very high overall level of agreement and acceptance (reaching international standard) on all the five areas of adherence within the eight statements of the finalised statement. Conclusions The present consensus statements are the first in Hong Kong to address systematically adherence issues in schizophrenia management. They include areas on adherence assessment and definition, treatment strategies in enhancing adherence, and treatment considerations at specific phases of schizophrenia. They are tailored to be of practical utility in the local Hong Kong setting.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>25440570</pmid><doi>10.1016/j.ajp.2014.06.018</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1876-2018
ispartof Asian journal of psychiatry, 2014-12, Vol.12, p.163-169
issn 1876-2018
1876-2026
language eng
recordid cdi_proquest_miscellaneous_1629959214
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adherence
Antipsychotic Agents - therapeutic use
Consensus
Consensus statements
Delphi Technique
Hong Kong
Humans
Internal Medicine
Medication Adherence
Psychiatry
Schizophrenia
Schizophrenia - drug therapy
title Consensus statements on adherence issues in schizophrenia for Hong Kong
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T21%3A18%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Consensus%20statements%20on%20adherence%20issues%20in%20schizophrenia%20for%20Hong%20Kong&rft.jtitle=Asian%20journal%20of%20psychiatry&rft.au=Mak,%20K.Y&rft.date=2014-12-01&rft.volume=12&rft.spage=163&rft.epage=169&rft.pages=163-169&rft.issn=1876-2018&rft.eissn=1876-2026&rft_id=info:doi/10.1016/j.ajp.2014.06.018&rft_dat=%3Cproquest_cross%3E1629959214%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1629959214&rft_id=info:pmid/25440570&rft_els_id=1_s2_0_S1876201814001750&rfr_iscdi=true